作者: C. Manning , L. Scandale , E. J. Manning , F. M. Gengo
DOI: 10.1002/J.1552-4604.1992.TB03801.X
关键词: Somnolence 、 Anesthesia 、 Dimenhydrinate 、 Randomized controlled trial 、 Histamine H1 receptor 、 Placebo 、 Crossover study 、 Drug tolerance 、 Medicine 、 Visual analogue scale
摘要: Relative daytime drowsiness and performance impairment produced by meclizine dimenhydrinate was assessed in 24 healthy male volunteers. Subjects received either dimenhydrinate, 100 mg, at 8:00 AM, 12:00 PM, 4:00 PM; meclizine, 50 with placebo PM or all three times this randomized, double-blind, three-way crossover study. Impairment of mental choice reaction time testing digit symbol substitution scores. Drowsiness self-assessed on the Stanford Sleepiness Scale a visual analog scale. Both antihistamines changes substitution, recognition time, subjective assessments sleepiness different from placebo. Expressed as change baseline, greatest reductions scores after occurred 3 hours first dose (6.6 +/- 7) were not measured (5.8 8), which 9 administered. Similar results obtained other psychometric test Self-rated 1 hour dose, significantly greater than largest degree 7 dose. The effects compared magnitude subsequent doses. effect data suggest possibility that acute tolerance to central nervous system develops multiple doses dimenhydrinate.